CAMKK2 activators described in Tohoku University patent

Oct. 11, 2023

Work at Tohoku University has led to the identification of new calcium/calmodulin-dependent protein kinase kinase 2 (CAMKK2; CAMKKβ) activators.

BioWorld Science Neurology/psychiatric Patents

Today's news in brief

BioWorld

BioWorld briefs for April 29, 2026.

News in brief

BioWorld Asia

BioWorld Asia briefs for April 28, 2026

Chinese biotechs gain leverage as partners in dealmaking

BioWorld

China’s biotech ecosystem has crossed an inflection point, and Chinese biotechs are gaining leverage in dealmaking, executives from multinational companies said...

Roche identifies new TREM2 agonists

BioWorld Science

F. Hoffmann-La Roche Ltd. and Hoffmann-La Roche Inc. have prepared and tested new compounds acting as triggering receptor expressed on myeloid cells 2 (TREM2)...

Plasticity, properly parsed, provides psychiatric platform

BioWorld

If Benjamin Braddock, of The Graduate fame, were a young neuroscientist in the 21st century instead of a liberal arts graduate in 1967, the advice he received...